RALGRO MAGNUM DIN 02224178
Health Canada record
| Active ingredient(s) | ZERANOL 72 MG |
|---|---|
| Dosage form | Implant |
| Route | Subcutaneous |
| Schedule | CONTROLLED DRUGS (CDSA IV) |
| Class | Veterinary |
| ATC | |
| Original market date | 15-Aug-1999 |
| Current status date | 04-Aug-2009 |
| Source | Health Canada DPD |
Establishment licence of the holder
Schering-Plough Mexico S.A. DE C.V. — licence , not currently licensed, last inspection rating C (2022-08-29).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ZERANOL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02137607 | RALGRO | INTERVET CANADA CORP | Implant | ZERANOL 36 MG | Marketed |
| 01919423 | RALGRO FE 72 IMPLANTS | COOPERS AGROPHARM INC. | Implant | ZERANOL 72 MG | Cancelled Post Market |
| 00882941 | RALGRO IMPLANTS 36MG | COOPERS AGROPHARM INC. | Implant | ZERANOL 36 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 9216 | 2007-12-03 | Supplement to a New Drug Submission (SNDS) | ALTERNATE MANUFACTURING SITE |
| 6590 | 1999-05-12 | New Drug Submission (NDS) | |
| 7056 | 1996-07-16 | New Drug Submission (NDS) |
International API supply for ZERANOL
0 active FDA Drug Master Files.
Request a quote for RALGRO MAGNUM